Mycobutin
Mycobutin is a medicine authorised by Swissmedic under authorisation number 52068. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 February 1994 and the authorisation is valid without a time limit. ATC code J04AB04 places the medicine in the group Antimycobacterials.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Mycobutin, Hartkapseln | A | 25 February 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 10 | 30 | Kapsel(n) | J04AB04 | 08.02.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Mycobutin authorised in Switzerland?
Yes. Mycobutin is authorised by Swissmedic under authorisation number 52068, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Mycobutin have?
Mycobutin is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Mycobutin?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.